CCIA
LFMD icon

Campbell & Co Investment Adviser’s LifeMD LFMD Stock Holding History

Campbell & Co Investment Adviser’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,361
Closed -$359K – 1255
2025
Q2 		$359K Buy
+26,361
New +$249K 0.02% 897

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Campbell & Co Investment Adviser's LFMD Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 26,361 shares — an estimated $359K sold.

Campbell & Co Investment Adviser first reported a position in LFMD in Q2 2025 and held it in 1 quarter. The position peaked at $359K in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 26,361 LifeMD shares in Q3 2025, an estimated $359K.
  • Campbell & Co Investment Adviser first reported a position in LifeMD in Q2 2025 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's LifeMD position peaked at $359K in Q2 2025.
  • 114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.